Tag: MRNA
Study: Prenatal Exposure to COVID-19 mRNA Vaccine BNT162b2 Induces Autism-Like Behaviors in Male Neonatal Rats
“Male rats exhibited pronounced autism-like behaviors, characterized by a marked reduction in social interaction and repetitive patterns of behavior.” More...
Study: Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine
An investigation by five German scientists of the variability of batches of the Pfizer/BionTech BNT162b2 mRNA COVID-19 vaccine, using a recent Danish study as the basis for their study. More...
mRNA vaccine booster dose antibodies – quantity not quality
“These results suggest that boosting vaccinated individuals with currently available mRNA vaccines would produce a quantitative increase in plasma neutralizing activity but not the qualitative advantage against variants obtained by vaccinating convalescent individuals.” More...
Canada: 82% Delta vaccine breakthrough in Calgary hospital coronavirus outbreak
An outbreak of the Delta coronavirus variant at the Foothills Medical Centre in Calgary has seen 16 patients and six health-care workers tested positive for the variant. More...
Preprint: vaccine breakthrough coronavirus infections may be common in transplant patients
“We studied 658 transplant recipients who received 2 doses of SARS-CoV-2 mRNA vaccine. More...
China’s first mRNA coronavirus vaccine ready for final stage trials overseas
China’s first domestically developed mRNA vaccine is ready to start its final stage trials overseas next month.The
Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2 coronavirus
Compared to immunocompetent controls, a three-fold reduction in anti-S IgG titers (P=0.009) and SARS-CoV-2 neutralization (p<0.0001) were observed in CID patients.
CDC: Moderna’s COVID-19 coronavirus vaccine could lead to more side effects than Pfizer/BioNTech’s
New research from the U.S. Centers for Disease Control and Prevention suggests that people who receive Moderna’s COVID-19 vaccine might experience more side effects than those who get Pfizer/BioNTech’s vaccine. More...
Evidence for increased vaccine breakthrough rates of coronavirus variants of concern in BNT162b2 Pfizer-BionTech mRNA vaccinated individuals
Here, we performed a case-control study that examined whether BNT162b2 (Pfizer-BionTech) vaccinees with documented SARS-CoV-2 infection were more likely to become infected with B.1.1.7 or B.1.351 compared with unvaccinated individuals. More...
Switzerland: Stage III hypertension in patients after mRNA-based SARS-CoV-2 coronavirus vaccination with Pfizer/Biontech & Moderna
On January 11th 2021, the vaccination Center in Lausanne, a city of 140’000 inhabitants in western Switzerland, started the COVID-19 vaccination with mRNA-based vaccines. More...